content

Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for Vekluryยฎ (remdesivir) for the...

Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,ย  announced that Australia's Therapeutic Goods Administration (TGA) has...

Sharp invests in new gene therapy packaging and distribution capacity at EU Heerenveen facility

Sharp, a global leader in contract packaging and clinical supply services, has completed the construction of new purpose-built production suites to facilitate the packaging,...

Bristol Myers Squibb Receives Approval for Abecma, the First CAR T Therapy Approved for the Treatment of Multiple Myeloma in Japan

Bristol-Myers Squibb announced that Japanโ€™s Ministry of Health, Labour and Welfare has approved Abecma (idecabtagene vicleucel), a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor...

TrakCel and Korber partner to provide orchestration within manufacturing of cell and gene therapies

TrakCel, a leading supplier of cellular orchestration solutions for the cell and gene therapy industry, announces it is launching a software integration resulting from...

Sterling Pharma Solutions Expands Early Phase Development Capabilities at Cary

Sterling Pharma Solutions, a global contract development and manufacturing organisation, announced that it has commenced a $2.1 million expansion project to increase chemical and...

West Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced an exclusive supply and technology agreement with Corning Incorporated....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read